化合物简介
Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the USA. In the USA since 2013, it is also approved for the treatment of depressive episodes associated with bipolar I disorder as well as bipolar II disorder in adults when used alone or in combination with lithium, valproate, or lamotrigine.
基本信息
中文名称
鲁拉西酮
英文名称
lurasidone
中文别名
英文别名
CAS号
367514-87-2
分子式
C28H36N4O2S
分子量
492.676
精确质量
492.256
PSA
84.99
LOGP
4.1966
编号系统
UNII
22IC88528T
生产方法及用途
用途
原料药。
